-
1
-
-
0031672540
-
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
-
Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
-
(1998)
Neurology
, vol.51
, pp. 1546-1554
-
-
Neary, D.1
Snowden, J.S.2
Gustafson, L.3
Passant, U.4
Stuss, D.5
Black, S.6
Freedman, M.7
Kertesz, A.8
Robert, P.H.9
Albert, M.10
Boone, K.11
Miller, B.L.12
Cummings, J.13
Benson, D.F.14
-
3
-
-
0033976206
-
Atypical and typical presentations of Alzheimer's disease: A clinical, neuropsychological, neuroimaging and pathological study of 13 cases
-
Galton CJ, Patterson K, Xuereb JH, Hodges JR: Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 2000;123:484-498.
-
(2000)
Brain
, vol.123
, pp. 484-498
-
-
Galton, C.J.1
Patterson, K.2
Xuereb, J.H.3
Hodges, J.R.4
-
4
-
-
0141738373
-
CSF markers for incipient Alzheimer's disease
-
Blennow K, Hampel H: CSF markers for incipient Alzheimer's disease. Lancet Neurology 2003;2:605-613.
-
(2003)
Lancet Neurology
, vol.2
, pp. 605-613
-
-
Blennow, K.1
Hampel, H.2
-
5
-
-
0034764622
-
Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease
-
McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ: Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58:1803-1809.
-
(2001)
Arch Neurol
, vol.58
, pp. 1803-1809
-
-
McKhann, G.M.1
Albert, M.S.2
Grossman, M.3
Miller, B.4
Dickson, D.5
Trojanowski, J.Q.6
-
6
-
-
20944439059
-
Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease
-
Grossman M, Farmer J, Leight S, Work M, Moore P, Van Deerlin V, Pratico D, Clark CM, Coslett HB, Chatterjee A, Gee J, Trojanowski JQ, Lee VM: Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Ann Neurol 2005;57:721-729.
-
(2005)
Ann Neurol
, vol.57
, pp. 721-729
-
-
Grossman, M.1
Farmer, J.2
Leight, S.3
Work, M.4
Moore, P.5
Van Deerlin, V.6
Pratico, D.7
Clark, C.M.8
Coslett, H.B.9
Chatterjee, A.10
Gee, J.11
Trojanowski, J.Q.12
Lee, V.M.13
-
7
-
-
4344580599
-
CSF tau and Abeta42 are not useful in the diagnosis of frontotemporal lobar degeneration
-
Pijnenburg YA, Schoonenboom NS, Rosso SM, Mulder C, Van Kamp GJ, Van Swieten JC, Scheltens P: CSF tau and Abeta42 are not useful in the diagnosis of frontotemporal lobar degeneration. Neurology 2004;62:1649.
-
(2004)
Neurology
, vol.62
, pp. 1649
-
-
Pijnenburg, Y.A.1
Schoonenboom, N.S.2
Rosso, S.M.3
Mulder, C.4
Van Kamp, G.J.5
Van Swieten, J.C.6
Scheltens, P.7
-
8
-
-
2342551973
-
-
Schoonenboom NS, Pijnenburg YA, Mulder C, Rosso SM, Van Elk EJ, Van Kamp GJ, Van Swieten JC, Scheltens P: Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease. Neurology 2004;62:1580-1584.
-
Schoonenboom NS, Pijnenburg YA, Mulder C, Rosso SM, Van Elk EJ, Van Kamp GJ, Van Swieten JC, Scheltens P: Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease. Neurology 2004;62:1580-1584.
-
-
-
-
9
-
-
2642525999
-
Total and phosphorylated tau proteins: Evaluation as core biomarker candidates in frontotemporal dementia
-
Hampel H, Teipel SJ: Total and phosphorylated tau proteins: evaluation as core biomarker candidates in frontotemporal dementia. Dement Geriatr Cogn Disord 2004;17:350-354.
-
(2004)
Dement Geriatr Cogn Disord
, vol.17
, pp. 350-354
-
-
Hampel, H.1
Teipel, S.J.2
-
10
-
-
0032559341
-
A structural scaffolding of intermediate filaments in health and disease
-
Fuchs E, Cleveland DW: A structural scaffolding of intermediate filaments in health and disease. Science 1998;279:514-519.
-
(1998)
Science
, vol.279
, pp. 514-519
-
-
Fuchs, E.1
Cleveland, D.W.2
-
11
-
-
12144265815
-
Neurofilament proteins in neurodegenerative diseases
-
Liu Q, Xie F, Siedlak SL, Nunomura A, Honda K, Moreira PI, Zhua X, Smith MA, Perry G: Neurofilament proteins in neurodegenerative diseases. Cell Mol Life Sci 2004;61:3057-3075.
-
(2004)
Cell Mol Life Sci
, vol.61
, pp. 3057-3075
-
-
Liu, Q.1
Xie, F.2
Siedlak, S.L.3
Nunomura, A.4
Honda, K.5
Moreira, P.I.6
Zhua, X.7
Smith, M.A.8
Perry, G.9
-
12
-
-
15944409728
-
Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss
-
Petzold A: Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 2005;233:183-198.
-
(2005)
J Neurol Sci
, vol.233
, pp. 183-198
-
-
Petzold, A.1
-
13
-
-
0029828676
-
Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF
-
Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkelso C: Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem 1996;67:2013-2018.
-
(1996)
J Neurochem
, vol.67
, pp. 2013-2018
-
-
Rosengren, L.E.1
Karlsson, J.E.2
Karlsson, J.O.3
Persson, L.I.4
Wikkelso, C.5
-
14
-
-
0031878572
-
Frontotemporal dementia: Neuropil spheroids and presynaptic terminal degeneration
-
Zhou L, Miller BL, McDaniel CH, Kelly L, Kim OJ, Miller CA: Frontotemporal dementia: neuropil spheroids and presynaptic terminal degeneration. Ann Neurol 1998;44:99-109.
-
(1998)
Ann Neurol
, vol.44
, pp. 99-109
-
-
Zhou, L.1
Miller, B.L.2
McDaniel, C.H.3
Kelly, L.4
Kim, O.J.5
Miller, C.A.6
-
15
-
-
0037426557
-
Patients with a novel neurofilamentopathy: Dementia with neurofilament inclusions
-
Cairns NJ, Perry RH, Jaros E, Burn D, McKeith IG, Lowe JS, Holton J, Rossor MN, Skullerud K, Duyckaerts C, Cruz-Sanchez FF, Lantos PL: Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett 2003;341:177-180.
-
(2003)
Neurosci Lett
, vol.341
, pp. 177-180
-
-
Cairns, N.J.1
Perry, R.H.2
Jaros, E.3
Burn, D.4
McKeith, I.G.5
Lowe, J.S.6
Holton, J.7
Rossor, M.N.8
Skullerud, K.9
Duyckaerts, C.10
Cruz-Sanchez, F.F.11
Lantos, P.L.12
-
16
-
-
0242336433
-
Neurofilament inclusion body disease:a new proteinopathy?
-
Josephs KA, Holton JL, Rossor MN, Braendgaard H, Ozawa T, Fox NC, Petersen RC, Pearl GS, Ganguly M, Rosa P, Laursen H, Parisi JE, Waldemar G, Quinn NP, Dickson DW, Revesz T: Neurofilament inclusion body disease:a new proteinopathy? Brain 2003;126:2291-2303.
-
(2003)
Brain
, vol.126
, pp. 2291-2303
-
-
Josephs, K.A.1
Holton, J.L.2
Rossor, M.N.3
Braendgaard, H.4
Ozawa, T.5
Fox, N.C.6
Petersen, R.C.7
Pearl, G.S.8
Ganguly, M.9
Rosa, P.10
Laursen, H.11
Parisi, J.E.12
Waldemar, G.13
Quinn, N.P.14
Dickson, D.W.15
Revesz, T.16
-
17
-
-
0343091321
-
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
-
Sjögren M, Rosengren L, Minthon L, Davidsson P, Blennow K, Wallin A: Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD. Neurology 2000;54:1960-1964.
-
(2000)
Neurology
, vol.54
, pp. 1960-1964
-
-
Sjögren, M.1
Rosengren, L.2
Minthon, L.3
Davidsson, P.4
Blennow, K.5
Wallin, A.6
-
19
-
-
0024237394
-
Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain
-
Pant HC: Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain. Biochem J 1988;256:665-668.
-
(1988)
Biochem J
, vol.256
, pp. 665-668
-
-
Pant, H.C.1
-
20
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease:report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
-
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease:report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
-
(1984)
Neurology
, vol.34
, pp. 939-944
-
-
McKhann, G.1
Drachman, D.2
Folstein, M.3
Katzman, R.4
Price, D.5
Stadlan, E.M.6
-
21
-
-
0027425211
-
The Clinical Dementia Rating (CDR): Current version and scoring rules
-
Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
-
(1993)
Neurology
, vol.43
, pp. 2412-2414
-
-
Morris, J.C.1
-
22
-
-
0142011171
-
Elevated neurofilament levels in neurological diseases
-
Norgren N, Rosengren L, Stigbrand T: Elevated neurofilament levels in neurological diseases. Brain Res 2003;987:25-31.
-
(2003)
Brain Res
, vol.987
, pp. 25-31
-
-
Norgren, N.1
Rosengren, L.2
Stigbrand, T.3
-
23
-
-
0142071146
-
A specific ELISA for measuring neurofilament heavy chain phosphoforms
-
Petzold A, Keir G, Green AJ, Giovannoni G, Thompson EJ: A specific ELISA for measuring neurofilament heavy chain phosphoforms. J Immunol Methods 2003;278:179-190.
-
(2003)
J Immunol Methods
, vol.278
, pp. 179-190
-
-
Petzold, A.1
Keir, G.2
Green, A.J.3
Giovannoni, G.4
Thompson, E.J.5
-
24
-
-
0027374233
-
Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay
-
Vandermeeren M, Mercken M, Vanmechelen E, Six J, van de Voorde A, Martin JJ, Cras P: Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J Neurochem 1993;61:1828-1834.
-
(1993)
J Neurochem
, vol.61
, pp. 1828-1834
-
-
Vandermeeren, M.1
Mercken, M.2
Vanmechelen, E.3
Six, J.4
van de Voorde, A.5
Martin, J.J.6
Cras, P.7
-
25
-
-
0033637408
-
Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma
-
Vanderstichele H, Van Kerschaver E, Hesse C, Davidsson P, Buyse MA, Andreasen N, Minthon L, Wallin A, Blennow K, Vanmechelen E: Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma. Amyloid 2000;7:245-258.
-
(2000)
Amyloid
, vol.7
, pp. 245-258
-
-
Vanderstichele, H.1
Van Kerschaver, E.2
Hesse, C.3
Davidsson, P.4
Buyse, M.A.5
Andreasen, N.6
Minthon, L.7
Wallin, A.8
Blennow, K.9
Vanmechelen, E.10
-
26
-
-
0034607960
-
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid; a sandwich ELISA with a synthetic phoshphopeptide for standardization
-
Vanmechelen E, Vanderstichele H, Davidsson P, Van Kerschaver E, Van Der Perre B, Sjögren M, Andreasen N, Blennow K: Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid; a sandwich ELISA with a synthetic phoshphopeptide for standardization. Neurosci Lett 2000;285:49-52.
-
(2000)
Neurosci Lett
, vol.285
, pp. 49-52
-
-
Vanmechelen, E.1
Vanderstichele, H.2
Davidsson, P.3
Van Kerschaver, E.4
Van Der Perre, B.5
Sjögren, M.6
Andreasen, N.7
Blennow, K.8
-
27
-
-
0033596812
-
Neurofilament protein levels in CSF are increased in dementia
-
Rosengren LE, Karlsson JE, Sjögren M, Blennow K, Wallin A: Neurofilament protein levels in CSF are increased in dementia. Neurology 1999;52:1090-1093.
-
(1999)
Neurology
, vol.52
, pp. 1090-1093
-
-
Rosengren, L.E.1
Karlsson, J.E.2
Sjögren, M.3
Blennow, K.4
Wallin, A.5
-
28
-
-
33646707066
-
The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease
-
Brettschneider J, Petzold A, Schottle D, Claus A, Riepe M, Tumani H: The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease. Dement Geriatr Cogn Disord 2006;21:291-295.
-
(2006)
Dement Geriatr Cogn Disord
, vol.21
, pp. 291-295
-
-
Brettschneider, J.1
Petzold, A.2
Schottle, D.3
Claus, A.4
Riepe, M.5
Tumani, H.6
-
29
-
-
0035121581
-
Cerebrospinal fluid tau levels increase with age in healthy individuals
-
Blomberg M, Jensen M, Basun H, Lannfelt L, Wahlund LO: Cerebrospinal fluid tau levels increase with age in healthy individuals. Dement Geriatr Cogn Disord 2001;12:127-132.
-
(2001)
Dement Geriatr Cogn Disord
, vol.12
, pp. 127-132
-
-
Blomberg, M.1
Jensen, M.2
Basun, H.3
Lannfelt, L.4
Wahlund, L.O.5
-
30
-
-
0034741554
-
Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age:establishment of reference values
-
Sjögren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, Wikkelso C, Skoog I, Wallin A, Wahlund LO, Marcusson J, Nagga K, Andreasen N, Davidsson P, Vanmechelen E, Blennow K: Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age:establishment of reference values. Clin Chem 2001;47:1776-1781.
-
(2001)
Clin Chem
, vol.47
, pp. 1776-1781
-
-
Sjögren, M.1
Vanderstichele, H.2
Agren, H.3
Zachrisson, O.4
Edsbagge, M.5
Wikkelso, C.6
Skoog, I.7
Wallin, A.8
Wahlund, L.O.9
Marcusson, J.10
Nagga, K.11
Andreasen, N.12
Davidsson, P.13
Vanmechelen, E.14
Blennow, K.15
-
31
-
-
7044262166
-
Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease
-
Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, Duyckaerts C, Stankoff B, Pillon B, Skullerud K, Cruz-Sanchez FF, Bigio EH, Mackenzie IR, Gearing M, Juncos JL, Glass JD, Yokoo H, Nakazato Y, Mosaheb S, Thorpe JR, Uryu K, Lee VM, Trojanowski JQ: Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 2004;63:1376-1384.
-
(2004)
Neurology
, vol.63
, pp. 1376-1384
-
-
Cairns, N.J.1
Grossman, M.2
Arnold, S.E.3
Burn, D.J.4
Jaros, E.5
Perry, R.H.6
Duyckaerts, C.7
Stankoff, B.8
Pillon, B.9
Skullerud, K.10
Cruz-Sanchez, F.F.11
Bigio, E.H.12
Mackenzie, I.R.13
Gearing, M.14
Juncos, J.L.15
Glass, J.D.16
Yokoo, H.17
Nakazato, Y.18
Mosaheb, S.19
Thorpe, J.R.20
Uryu, K.21
Lee, V.M.22
Trojanowski, J.Q.23
more..
|